Sign In

Ned Wakeman

Director & Founder of Lean Life Science & CEO of NanOptima Ltd

Ned Wakeman is an accomplished professional currently serving as the Co-founder and Chief Business Officer (CBO) at Clot Protect Limited.1 He is known for his entrepreneurial spirit and strategic thinking, with a background that includes significant experience in the life sciences and biotechnology sectors.1

Professional Background

Ned Wakeman has held several notable positions throughout his career:

  • Director & Founder of Lean Life Science: He is involved in oncology development programs.23
  • Director of BioHub: Wakeman served as the Director of the BioHub at Alderley Park Accelerator for 8 years.5
  • Co-founder and Director: He was also involved with the Alderley Park Oncology Development Program.5

Areas of Expertise

Wakeman's professional interests and expertise appear to span several areas:

  • Venture capital
  • Technology
  • Biotechnology
  • Oncology development
  • Ophthalmology

His LinkedIn posts indicate ongoing engagement with topics such as venture capital, technology, and specific medical fields like ophthalmology.23

Personal Interests

Outside of his professional life, Ned Wakeman seems to have a passion for photography and family, as mentioned in his Threads profile.4

Ned Wakeman's career trajectory showcases a strong focus on innovation in the life sciences sector, particularly in areas such as oncology and biotechnology startups. His role at Clot Protect Limited appears to be a continuation of his work in developing and advancing medical technologies and treatments.

Related Questions

What is Clot Protect Limited's mission and focus?
What are some of Ned Wakeman's notable achievements at Clot Protect Limited?
How did Ned Wakeman transition from the BioHub to Clot Protect Limited?
What other companies has Ned Wakeman founded or been involved with?
What is Ned Wakeman's educational background?
Ned Wakeman
Ned Wakeman, photo 1
Ned Wakeman, photo 2
Add to my network

Experience

Director & Founder at Lean Life Science since March 2022; CEO at NanOptima Ltd since February 2016
Advisory Board at Alderley Park Ventures Ltd (APV) since January 2015; Director at Alderley Park Oncology Development Programme from September 2020 to March 2022

Education

B.A. in English from Colgate University (1977-1981); Clinical Psychology at California School of Professional Psychology (1984-1986); Neuropsychopharmacology (research) at Yale University School of Medicine (1981-1983); Experimental Psychology at University of Oxford (1989-1996)

Location

Macclesfield, England, United Kingdom